| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/08/1996 | CA2211973A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc |
| 08/08/1996 | CA2211916A1 New pharmaceutical composition containing trimebutine and preparation process |
| 08/08/1996 | CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals |
| 08/08/1996 | CA2211189A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists |
| 08/08/1996 | CA2211099A1 Modified ligands for receptor tyrosine kinases |
| 08/07/1996 | EP0725062A1 4-mercapto-benzoylguanidine derivatives |
| 08/07/1996 | EP0724884A1 Side effect inhibitor for cancer therapy |
| 08/07/1996 | EP0724881A1 Method for treating smoking-related bone loss |
| 08/07/1996 | EP0724879A2 2-Phenyl-3-azoylbenzothiopenes for inhibiting effects of IL-6 |
| 08/07/1996 | EP0724877A1 Mixture of fenofibrate and vitamin E and its therapeutic use |
| 08/07/1996 | EP0724832A1 Properties of cats' facial pheromones |
| 08/07/1996 | EP0724647A1 Nucleic acid ligands and improved methods for producing the same |
| 08/07/1996 | EP0724600A1 Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained |
| 08/07/1996 | EP0724599A1 Platelet-derived growth factor analogues |
| 08/07/1996 | EP0724594A1 Regulation of transcription factor, nf-il6/lap |
| 08/07/1996 | EP0724591A1 Delta 16 unsaturated c 17 heterocyclic steroids useful as steroid c 17-20 lyase inhibitors |
| 08/07/1996 | EP0724589A1 A method for enhancing neurone survival and agents useful for same |
| 08/07/1996 | EP0724583A1 Pyridazino quinoline compounds |
| 08/07/1996 | EP0724579A1 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
| 08/07/1996 | EP0724572A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands |
| 08/07/1996 | EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/07/1996 | EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
| 08/07/1996 | EP0724561A1 Calcium receptor-active arylalkyl amines |
| 08/07/1996 | EP0724457A1 Radiation sensitization using texaphyrins |
| 08/07/1996 | EP0724443A1 Methods and compositions for lowering intraocular pressure |
| 08/07/1996 | EP0724441A1 Picosulphate dosage form |
| 08/07/1996 | EP0724440A1 Di- and tetra-hydrobenzo f]quinolin-3-ones |
| 08/07/1996 | EP0724439A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents |
| 08/07/1996 | EP0724435A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/07/1996 | EP0724425A1 New use of prostaglandins |
| 08/07/1996 | EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists |
| 08/07/1996 | EP0661981B1 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 08/07/1996 | CN1128531A Therapeutic compound-fatty acid conjugates |
| 08/07/1996 | CN1128269A Oligoribonucleotides with amide backbone |
| 08/07/1996 | CN1128264A Crystalline form of dihydro-2,3-benzodiazepine derivative |
| 08/07/1996 | CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity |
| 08/07/1996 | CN1128262A Substituted biphenyl isoxazole sulfonamides |
| 08/07/1996 | CN1128261A Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative |
| 08/07/1996 | CN1128260A New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them |
| 08/07/1996 | CN1032470C Method for processing sulfur-containing heterocyclic compound |
| 08/06/1996 | US5543528 Useful as angiotensin ii antagonist |
| 08/06/1996 | US5543527 Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-nitro-1H-imidazol-1-ethanol and related compounds |
| 08/06/1996 | US5543430 Method and formulation of stimulating nitric oxide synthesis |
| 08/06/1996 | US5543426 Use of certain 3,7-disubstituted indole compounds for treating depression or cognitive disorders |
| 08/06/1996 | US5543420 Aldose reductase inhibitors; antidiabetic agents; prevention of accumulation of sorbitol and galactitol in mammalian tissue |
| 08/06/1996 | US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements |
| 08/06/1996 | US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
| 08/06/1996 | US5543392 Containing epidermal growth factor |
| 08/06/1996 | US5543140 Method and use of IL-1α |
| 08/01/1996 | WO1996023225A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 08/01/1996 | WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 08/01/1996 | WO1996023059A1 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 08/01/1996 | WO1996023000A1 Ligands for eph-like receptors |
| 08/01/1996 | WO1996022997A1 Compounds with growth hormone releasing properties |
| 08/01/1996 | WO1996022992A1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists |
| 08/01/1996 | WO1996022990A2 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists |
| 08/01/1996 | WO1996022979A1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors |
| 08/01/1996 | WO1996022978A1 Substituted phenyl compounds as endothelin antagonists |
| 08/01/1996 | WO1996022976A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 08/01/1996 | WO1996022966A1 Cell adhesion inhibitors |
| 08/01/1996 | WO1996022790A1 Composition to ameliorate osteolysis and metastasis |
| 08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
| 08/01/1996 | WO1996022785A1 Methods for the treatment of acid aspiration-induced acute lung injury |
| 08/01/1996 | WO1996022779A1 Muscular dystrophy progression depressant |
| 08/01/1996 | WO1996022774A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins |
| 08/01/1996 | WO1996016170A3 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 08/01/1996 | WO1996006604A3 Methods for identifying and treating resistant tumors |
| 08/01/1996 | CA2211608A1 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists |
| 08/01/1996 | CA2211212A1 Tricyclic substituted hexahydrobenz¬e|isoindole alpha-1 adrenergic antagonists |
| 08/01/1996 | CA2211181A1 Cell adhesion inhibitors |
| 08/01/1996 | CA2211176A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 08/01/1996 | CA2211115A1 Methods for the treatment of acid aspiration-induced acute lung injury |
| 08/01/1996 | CA2210644A1 Ligands for eph-like receptors |
| 08/01/1996 | CA2168067A1 Method for treating smoking-related bone loss |
| 07/31/1996 | EP0723974A1 Derivatives of mercaptoalkanoyldipeptides, their preparation and pharmaceutical compositions containing them |
| 07/31/1996 | EP0723969A1 Phosphonocarboxylic acid derivatives and their use in treating degenerative articular ailments |
| 07/31/1996 | EP0723962A1 Arylalkyl-thiadiazinones |
| 07/31/1996 | EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them |
| 07/31/1996 | EP0723779A1 Medicament for treatment of hypothalamic amenorrhea |
| 07/31/1996 | EP0723778A1 Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde |
| 07/31/1996 | EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP |
| 07/31/1996 | EP0723588A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
| 07/31/1996 | EP0723553A1 Compounds useful in anti-allergy treatment |
| 07/31/1996 | EP0723552A1 Oligopeptides derived from c-reactive protein fragments |
| 07/31/1996 | EP0723541A1 Indole derivatives as nmda antagonists |
| 07/31/1996 | EP0723537A1 Benzothiophenes and related compounds as estrogen agonists |
| 07/31/1996 | EP0723455A1 Methods of inhibiting phagocytosis |
| 07/31/1996 | EP0723441A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 07/31/1996 | EP0723439A1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 07/31/1996 | EP0723438A1 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 07/31/1996 | EP0491849B1 A method for the purification of transforming growth factor (tgf-) |
| 07/31/1996 | EP0472661B1 Therapeutic application of an anti-invasion compound |
| 07/31/1996 | CN1128044A Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 07/31/1996 | CN1128029A Thiazole derivatives as lipoxygenase inhibitors |
| 07/31/1996 | CN1128028A N-morpholino-N-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 07/31/1996 | CN1128022A Nipecotic acid derivatives as antithrombic compounds |
| 07/31/1996 | CN1127753A New imidazolidines substituted by a heterocycle, their preparation process and intermediates, their use as medicaments NAD the pharmaceutical compositions containing them |
| 07/31/1996 | CN1127752A Method of manufacturing the cycloheptimidazole derivatives |
| 07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 07/31/1996 | CA2167999A1 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |